In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

Evaluation of the in vitro interaction of doripenem and amikacin against Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae was done by classifying them into four groups: doripenem and amikacin sensitive (DOR-S/AMK-S), doripenem sensitive and amikacin resistant (DOR-S/AMK-R),...

Full description

Saved in:
Bibliographic Details
Main Authors: Tonny Loho, Ninik Sukartini, Dalima A. W. Astrawinata, Suzanna Immanuel, Diana Aulia, Ika Priatni
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2018/1047670
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849412135784808448
author Tonny Loho
Ninik Sukartini
Dalima A. W. Astrawinata
Suzanna Immanuel
Diana Aulia
Ika Priatni
author_facet Tonny Loho
Ninik Sukartini
Dalima A. W. Astrawinata
Suzanna Immanuel
Diana Aulia
Ika Priatni
author_sort Tonny Loho
collection DOAJ
description Evaluation of the in vitro interaction of doripenem and amikacin against Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae was done by classifying them into four groups: doripenem and amikacin sensitive (DOR-S/AMK-S), doripenem sensitive and amikacin resistant (DOR-S/AMK-R), doripenem resistant and amikacin sensitive (DOR-R/AMK-S), and both doripenem and amikacin resistant (DOR-R/AMK-R). The MIC of each antibiotic and their combination was obtained using the Etest method. The fractional inhibitory concentration index was calculated to classify the results as synergistic, additive, indifferent, or antagonistic interaction. In the DOR-S/AMK-S class, 1 isolate of A. baumannii showed synergy and the other 5 showed additive results, 5 isolates of P. aeruginosa showed additive and 1 isolate showed indifferent result, and 2 isolates of K. pneumoniae showed additive and the other 4 showed indifferent results. In the DOR-S/AMK-R class, 3 isolates of A. baumannii showed additive and the other 3 showed indifferent results, 2 isolates of P. aeruginosa showed indifferent results, and 1 isolate of K. pneumoniae showed additive and the other 5 showed indifferent results. In the DOR-R/AMK-S class, 1 isolate of A. baumannii showed additive and the other 5 showed indifferent results, 1 isolate of P. aeruginosa showed additive and the other 5 showed indifferent results, and 4 isolates of K. pneumoniae showed additive and the other 2 showed indifferent results. In the DOR-R/AMK-R class, 6 isolates of A. baumannii showed indifferent results, 1 isolate of P. aeruginosa showed additive and the other 5 showed indifferent results, and 1 isolate of K. pneumoniae showed additive and the other 5 showed indifferent results. Synergy occurred in only 1 (1.5%) isolate. Additive interaction occurred in 24 (35.3%) isolates, and indifferent interaction occurred in 43 (63.2%) isolates. Doripenem sensitive combined with amikacin sensitive reduced MIC significantly in all bacterial isolates when compared to single MIC of each antibiotic.
format Article
id doaj-art-5e6dffcd1bea4899aff76972e13f281e
institution Kabale University
issn 1712-9532
1918-1493
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-5e6dffcd1bea4899aff76972e13f281e2025-08-20T03:34:32ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95321918-14932018-01-01201810.1155/2018/10476701047670In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae IsolatesTonny Loho0Ninik Sukartini1Dalima A. W. Astrawinata2Suzanna Immanuel3Diana Aulia4Ika Priatni5Infectious Diseases Division, Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaInfectious Diseases Division, Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaInfectious Diseases Division, Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaInfectious Diseases Division, Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaInfectious Diseases Division, Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaInfectious Diseases Division, Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaEvaluation of the in vitro interaction of doripenem and amikacin against Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae was done by classifying them into four groups: doripenem and amikacin sensitive (DOR-S/AMK-S), doripenem sensitive and amikacin resistant (DOR-S/AMK-R), doripenem resistant and amikacin sensitive (DOR-R/AMK-S), and both doripenem and amikacin resistant (DOR-R/AMK-R). The MIC of each antibiotic and their combination was obtained using the Etest method. The fractional inhibitory concentration index was calculated to classify the results as synergistic, additive, indifferent, or antagonistic interaction. In the DOR-S/AMK-S class, 1 isolate of A. baumannii showed synergy and the other 5 showed additive results, 5 isolates of P. aeruginosa showed additive and 1 isolate showed indifferent result, and 2 isolates of K. pneumoniae showed additive and the other 4 showed indifferent results. In the DOR-S/AMK-R class, 3 isolates of A. baumannii showed additive and the other 3 showed indifferent results, 2 isolates of P. aeruginosa showed indifferent results, and 1 isolate of K. pneumoniae showed additive and the other 5 showed indifferent results. In the DOR-R/AMK-S class, 1 isolate of A. baumannii showed additive and the other 5 showed indifferent results, 1 isolate of P. aeruginosa showed additive and the other 5 showed indifferent results, and 4 isolates of K. pneumoniae showed additive and the other 2 showed indifferent results. In the DOR-R/AMK-R class, 6 isolates of A. baumannii showed indifferent results, 1 isolate of P. aeruginosa showed additive and the other 5 showed indifferent results, and 1 isolate of K. pneumoniae showed additive and the other 5 showed indifferent results. Synergy occurred in only 1 (1.5%) isolate. Additive interaction occurred in 24 (35.3%) isolates, and indifferent interaction occurred in 43 (63.2%) isolates. Doripenem sensitive combined with amikacin sensitive reduced MIC significantly in all bacterial isolates when compared to single MIC of each antibiotic.http://dx.doi.org/10.1155/2018/1047670
spellingShingle Tonny Loho
Ninik Sukartini
Dalima A. W. Astrawinata
Suzanna Immanuel
Diana Aulia
Ika Priatni
In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
Canadian Journal of Infectious Diseases and Medical Microbiology
title In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
title_full In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
title_fullStr In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
title_full_unstemmed In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
title_short In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
title_sort in vitro antibacterial interaction of doripenem and amikacin against multidrug resistant acinetobacter baumannii pseudomonas aeruginosa and klebsiella pneumoniae isolates
url http://dx.doi.org/10.1155/2018/1047670
work_keys_str_mv AT tonnyloho invitroantibacterialinteractionofdoripenemandamikacinagainstmultidrugresistantacinetobacterbaumanniipseudomonasaeruginosaandklebsiellapneumoniaeisolates
AT niniksukartini invitroantibacterialinteractionofdoripenemandamikacinagainstmultidrugresistantacinetobacterbaumanniipseudomonasaeruginosaandklebsiellapneumoniaeisolates
AT dalimaawastrawinata invitroantibacterialinteractionofdoripenemandamikacinagainstmultidrugresistantacinetobacterbaumanniipseudomonasaeruginosaandklebsiellapneumoniaeisolates
AT suzannaimmanuel invitroantibacterialinteractionofdoripenemandamikacinagainstmultidrugresistantacinetobacterbaumanniipseudomonasaeruginosaandklebsiellapneumoniaeisolates
AT dianaaulia invitroantibacterialinteractionofdoripenemandamikacinagainstmultidrugresistantacinetobacterbaumanniipseudomonasaeruginosaandklebsiellapneumoniaeisolates
AT ikapriatni invitroantibacterialinteractionofdoripenemandamikacinagainstmultidrugresistantacinetobacterbaumanniipseudomonasaeruginosaandklebsiellapneumoniaeisolates